139 related articles for article (PubMed ID: 36377848)
1. Biased Activation Mechanism Induced by GPCR Heterodimerization: Observations from μOR/δOR Dimers.
Chen X; Yuan Y; Chen Y; Yu J; Wang J; Chen J; Guo Y; Pu X
J Chem Inf Model; 2022 Nov; 62(22):5581-5600. PubMed ID: 36377848
[TBL] [Abstract][Full Text] [Related]
2. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation.
Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608
[TBL] [Abstract][Full Text] [Related]
3. Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers.
Rozenfeld R; Devi LA
FASEB J; 2007 Aug; 21(10):2455-65. PubMed ID: 17384143
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into the allosteric coupling mechanism between an agonist and two different transducers for μ-opioid receptors.
Zhang F; Yuan Y; Chen Y; Chen J; Guo Y; Pu X
Phys Chem Chem Phys; 2022 Mar; 24(9):5282-5293. PubMed ID: 35170592
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
Mafi A; Kim SK; Goddard WA
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
[TBL] [Abstract][Full Text] [Related]
7. Exploring biased activation characteristics by molecular dynamics simulation and machine learning for the μ-opioid receptor.
Chen J; Gou Q; Chen X; Song Y; Zhang F; Pu X
Phys Chem Chem Phys; 2024 Apr; 26(14):10698-10710. PubMed ID: 38512140
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
[TBL] [Abstract][Full Text] [Related]
9. Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.
Gomes I; Fujita W; Gupta A; Saldanha SA; Negri A; Pinello CE; Eberhart C; Roberts E; Filizola M; Hodder P; Devi LA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12072-7. PubMed ID: 23818586
[TBL] [Abstract][Full Text] [Related]
10. Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation.
Patierno S; Anselmi L; Jaramillo I; Scott D; Garcia R; Sternini C
Gastroenterology; 2011 Feb; 140(2):618-26. PubMed ID: 21070774
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 1A receptor regulates β-arrestin binding of the β
Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
[TBL] [Abstract][Full Text] [Related]
12. mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis.
Hojo M; Sudo Y; Ando Y; Minami K; Takada M; Matsubara T; Kanaide M; Taniyama K; Sumikawa K; Uezono Y
J Pharmacol Sci; 2008 Nov; 108(3):308-19. PubMed ID: 19008645
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.
Wang H; Hetzer F; Huang W; Qu Q; Meyerowitz J; Kaindl J; Hübner H; Skiniotis G; Kobilka BK; Gmeiner P
Angew Chem Int Ed Engl; 2022 Jun; 61(26):e202200269. PubMed ID: 35385593
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of fentanyl mediated β-arrestin biased signaling.
de Waal PW; Shi J; You E; Wang X; Melcher K; Jiang Y; Xu HE; Dickson BM
PLoS Comput Biol; 2020 Apr; 16(4):e1007394. PubMed ID: 32275713
[TBL] [Abstract][Full Text] [Related]
15. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
[TBL] [Abstract][Full Text] [Related]
17. Enhanced morphine analgesia in mice lacking beta-arrestin 2.
Bohn LM; Lefkowitz RJ; Gainetdinov RR; Peppel K; Caron MG; Lin FT
Science; 1999 Dec; 286(5449):2495-8. PubMed ID: 10617462
[TBL] [Abstract][Full Text] [Related]
18. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
19. β-Arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice.
Ko MJ; Chiang T; Mukadam AA; Mulia GE; Gutridge AM; Lin A; Chester JA; van Rijn RM
Sci Signal; 2021 Aug; 14(694):. PubMed ID: 34344831
[TBL] [Abstract][Full Text] [Related]
20. Allosteric coupling and biased agonism in G protein-coupled receptors.
Bock A; Bermudez M
FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
